Jon Congleton, CEO: Mineralys Therapeutics MLYS Sell · Filed 25/10/15

Trade details

Type: Insider sale
Amount: $577,551.24
Shares · price: 13,548 sh · $42.63 a share
Held after: 832,857 sh
Stock: Mineralys Therapeutics MLYS
Person: Jon CongletonCEO
Trade date: 25/10/13
Filed: 25/10/15
Days to filing: 2 days

Sold 1.6% of holdings

Share of holding sold: 1.6%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/13~25/11/12

Jon Congleton's recent trades

Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$291.4K
10,700 sh
$291.4K
Filed 07/13
Traded 07/13
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$1.5M
58,000 sh
$1.5M
Filed 06/30
Traded 06/30
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$455.9K
17,000 sh
$455.9K
Filed 06/30
Traded 06/30
Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$2M
75,000 sh
$2M
Filed 06/30
Traded 06/30
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$422K
15,730 sh
$422K
Filed 04/15
Traded 04/13

Jon Congleton, CEO — sold $577.6K of Mineralys Therapeutics MLYS · 1.6% of holdings · 10b5-1 plan | Whalegun